Head and Neck Cancer Diagnostic Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027, Segmented By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics), By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others), By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing), By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy), By Dental Diagnostics
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationHead and Neck Cancer Diagnostic Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027, Segmented By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics), By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others), By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing), By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy), By Dental Diagnostics
The global head and neck cancer diagnostic market is expected to grow at an impressive CAGR in the forecast period, 2023-2027. The increasing geriatric population who are more prone to numerous chronic diseases such as cancer is driving the growth of the global head and neck cancer diagnostic market.
Inflating disposable income leads to increased healthcare expenditure by the people. Furthermore, the escalating demand for diagnostic imaging, advancing treatment modes, and the incorporation of novel technologies in diagnostics equipment by the market players are expected to stimulate market growth. Also, the increased adoption of sedentary lifestyles and modifications in dietary habits is giving rise to several incidences among consumers, which further contributes to the global head and neck cancer diagnostics market growth. The growing need for targeted therapies and the awareness among the people regarding the availability and effectiveness of several oncological treatment procedures are expected to influence the global head and neck cancer diagnostic market growth in the forecast period.
Increasing Incidences of Cancer Propels the Market Growth
Cancer refers to the uncontrolled and abnormal growth of cells that form a mass known as a tumour that can be cancerous or benign. The adoption of sedentary lifestyles, especially among the working population, leads to various chronic illnesses, including cancer. The growing old age population who are more prone to any chronic diseases as their immune system gets weak further supports the growth of the global head and neck cancer diagnostics market. As per a study by the National Center for Biotechnology Information, head and neck cancer is considered the sixth-most common cancer globally. Regular consumption of tobacco and excessive alcohol consumption also increases the risk of head and neck cancer in consumers.
Rise In Demand for Diagnostic Imaging Equipment Fuels the Market Growth
Diagnostic imaging refers to the technique and procedure of creating visual representations of the interior of a body for medical intervention, visual representation of the function of some organs or tissues, and clinical analysis of any organ. Head and neck cancer refers to the group of cancers that generally begins in the squamous cells that line the mouth, nose, neck, and throat. To detect the accurate location of these kinds of cancer and determine if it has spread, head MRI, CT of the sinuses, head CT, clinical analysis and panoramic dental x-ray, dental cone beam CT, PET/CT, or chest imaging are few of the common diagnostic procedures which are performed upon the patients.
Elevating Need for Effective Targeted Treatment Boosts the Market Growth
Click here to download the sample
Market Segmentation
head and neck cancer
Market Players
Addent Inc, GE Healthcare, Koninklijke Philips NV, Shimadzu Corporation, Siemens Healthineers AG, Fujifilm Holdings Corporation, Canon Medical system Corporation, Carestream Healthcare Inc., Neusoft Medical Systems Co., Ltd., Varian Medical Systems, Inc. are the key market players leading the growth of the global head and neck cancer diagnostics market.
| Attribute | Details |
| Base Year | 2021 |
| Historic Data | 2017 – 2020 |
| Estimated Year | 2022 |
| Forecast Period | 2023 – 2027 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027 |
| Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | · Type · End-User |
| Regional scope | North America; Asia Pacific; Europe; South America; Middle East & Africa |
| Country scope | United States; Canada; Mexico; China; India; Japan; South Korea; Australia; Singapore; Malaysia; Germany; United Kingdom; France; Italy; Spain; Poland; Denmark; Brazil; Argentina; Colombia; Poland; Denmark; Saudi Arabia; South Africa; UAE; Iraq; Turkey |
| Key companies profiled | Addent Inc, GE Healthcare, Koninklijke Philips NV, Shimadzu Corporation, Siemens Healthineers AG, Fujifilm Holdings Corporation, Canon Medical system Corporation, Carestream Healthcare Inc., Neusoft Medical Systems Co., Ltd., Varian Medical Systems, Inc. |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy